Replies to post #799519 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

It is not a wealth generator, it's a wealth destroyer!

NWBO is down:
Over 8% in the last six months
Over 12% in the last year
Over 80% in the last five years
Over 94% in the last ten years
Over 99% since going public

If approval was imminent and ''generational wealth'' is just around the corner, the market wouldn't be pricing NWBO as terminally distressed penny stock. The market has voted consistently - and it has voted no!

[jondoeuk]

''Advancing in collaboration with Merck, with eight Phase 2 and Phase 3 clinical trials underway across multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), bladder cancer and renal cell carcinoma.'' https://www.nasdaq.com/press-release/moderna-analyst-day-highlights-pipeline-progress-and-business-strategy-updates-2025

[exwannabe]

You don't know Merck has the [BCG] monopoly?

SII (Moscow 338) is the largest manufacturer.
AJ Bio (Danish 1331) supplies the UK.
Japan BCG Lab (Tokyo 172-1) was used by NWBO as an API in Direct. This is a different strain than Merck's (TICE), and it is them that had the monopoly on that supply.

Merck was the only FDA approved BCG vaccine (SII now is also). But that FDA approval of the final vaccine is not what is needed as an API going into a final product.

You can find all the above is seconds even with your crappy AI. Or you can go to actuall sources and get it officially (other than the NWBO supplier, listed in the Direct method B patent).